Our Blogs & News

Beyond the CE Mark: Is Your Importing Strategy EUDAMED-Ready?​

The implementation of EU MDR and IVDR is a journey of critical milestones, and the most significant one is now upon us. As the mandatory transition to EUDAMED approaches, your strategy for Medical Device EU Importing 2026 must evolve to maintain market access.

For non-EU manufacturers, holding a CE mark is no longer the final step. To maintain market access, you must now navigate the phased implementation of EUDAMED, the European database for medical devices. This isn’t just a digital filing cabinet; it is the backbone of transparency and safety in the EU.

Now is the moment to audit your importing strategy. As EUDAMED modules for Actor and Device registration become mandatory, your choice of Importer determines your ability to generate a Single Registration Number (SRN) and keep your supply chain moving.

 

Why the “Distributor-as-Importer” Model can create bottlenecks

With stricter EUDAMED oversight and Notified Body bottlenecks, the old way of importing can become a liability:

  •  Commercial “Lock-in” & Market Conflict: Tying your legal importer address to one distributor makes switching partners or adding new sales channels a labeling nightmare. You lose the flexibility to scale a multi-channel strategy.
  • The Liability & Capability Gap: Importers now share joint liability for compliance. Most distributors lack the RA/QA infrastructure to manage EUDAMED Actor profiles or perform mandatory Article 13 checks.
  • Administrative Burnout: EUDAMED requires importers to link themselves to your devices and update data within one week of any change. Many distributors are now refusing these burdens, stalling your product launch.

 

What You’ll Discover in This Practical Guide:

  • The 2026 Compliance Roadmap: Key deadlines for Actor and Device registration in EUDAMED.
  • Regulatory vs. Fiscal Silos: How to design a setup where compliance and cash flow (VAT Article 23) work in harmony.
  • The Netherlands Advantage: Why the Dutch “Hub” is the trending choice for centralized EU medical device logistics.
  • The “Importer Onboarding Pack”: A checklist of exactly what you need to prepare—from UDI-DI mapping to Quality Agreements—to avoid shipment holds.

 

Ready to guarantee importer compliance, place your medical device and In Vitro Devices seamless, efficient and independent in the EU, UK and CH markets?

GrowthMedics provides the independent, ISO 13485-standard importing infrastructure you need to bypass distributor conflict and EUDAMED delays.

  • Total Flexibility: Add or change distributors without relabeling.
  • Data Security: Your technical documentation stays with an independent regulatory partner, not a sales agent.
  • Fiscal Efficiency: Leverage our Netherlands-based expertise for seamless customs and VAT management.
 

Interested to learn more? Book a meeting with us here directly for a free consultation or:

Learn how non-EU medical device manufacturers can stay MDR-compliant. This whitepaper explains what qualifies as an MDR importer, the risks of designating distributors, the legal

The new EU MDR/IVDR regulations redefine the responsibilities of manufacturers, importers, and distributors—creating new risks for non-EU companies. This whitepaper explains why appointing your distributor

Europe/MENA quickly—bringing market know-how, KOL/distributor/hospital networks, and a proven outreach engine—while keeping costs, risk, and commitments low. You’ll compare SDaaS against hiring employees, independent reps,

Discover where Europe’s MedTech momentum lives. This overview maps the continent’s most active clusters—BioValley, BioRN, Medicon Valley, HTGF, MedTech Twente, BioM, Catalonia’s BioRegion, BioCity, Oxford

Europe is the world’s second-largest MedTech market, offering vast opportunities—but also complex challenges. This e-book is your step-by-step guide to navigating them. You’ll learn how

From 14 to 55 distributors and 3.5x revenue growth in 3 years — discover how GrowthMedics helped a U.S. healthcare manufacturer scale across Europe. The

From zero presence to six exclusive distributors in 12 months—see how GrowthMedics launched a new veterinary rehab technology across Europe and the Middle East. The

When your domestic market matures, or if you are looking to scale revenue, growth means going global. Learn how GrowthMedics guided a U.S. infection control

Hiring in Europe is risky and costly. With GrowthMedics, this U.S. orthopedic supplier built trust, landed OEM projects, and secured long-term growth without the overhead.

For medical device start-ups, funding is tight and risks are high, especially for new innovations. Discover how GrowthMedics turned limited resources into distributor, KOL traction

12 distributor meetings, 2 purchase orders, and rising online visibility—see how GrowthMedics built a digital growth engine for a U.S. veterinary brand in Europe. The

🌏 The growth potential in international markets are significant but not an easy task. Especially for medical companies with little presence in international markets. More

Managing international sales from oversees, without having local adequate sales representation, brings a variety of operational complexities and significantly delays sales success, GrowthMedics provides dedicated

Expanding into international markets is challenging and capital-intensive, yet the potential rewards are substantial. What is currently preventing you from capturing this growth?

In today’s healthcare landscape, patients are no longer passive recipients of information — they’re informed, digitally savvy decision-makers who research symptoms, compare providers, read reviews,

The European MedTech market is one of the most dynamic and competitive in the world. Yet, navigating this fragmented landscape of regulations, cultures, and stakeholders

Digital marketing is no longer just an option but an essential blueprint for any business looking to succeed in this modern environment. It’s not just

You may or may not have had your annual sales meetings with your distributors, if you haven’t it’s a critical moment to set out plans,

Expanding into new markets, such as Europe or the Middle East, can be a significant opportunity for medical device manufacturers looking to grow their business.

The world is facing challenges such as geopolitical and economical events resulting into inflation and shortages in the supply chain. The new Medical Device Regulation

Per April 2023 Canadian medical manufacturers can apply for a funding for fiscal year 2023 and 2024! Don’t miss out on this opportunity and read

IVDR/MDR Regulations Extended to Combat Medical Device Supply Shortage Recently, a significant development has come to pass concerning the implementation of the EU’s new medical

Accessing the Swiss medical device market with FDA approval The swiss medtech approves medical device manufacturers enter the Swiss healthcare market with FDA. This is

European Anesthesia Market Overview The European medical technology market as a whole is enormous – about €170 billion in 2024, making Europe the world’s second-largest

A Growing Market Fuelled by Demand The European catheter market is experiencing steady and robust growth. This is largely due to an aging population, a

European IV Market Overview IV access products are a cornerstone of modern healthcare, as intravenous therapy is used daily across hospitals and clinics for hydration,

At GrowthMedics, we are proud to support global veterinary device manufacturers in establishing a robust presence in the dynamic European veterinary healthcare market. By leveraging

In the ever-evolving landscape of the orthopedic and surgical industries, expanding into the European orthopaedic and spinal market offers immense opportunities alongside unique challenges. At

At GrowthMedics we specialize in supporting CMO’s with their expansion through European OEM markets. From injection molded solutions, coating services, to wearables, catethers, electronics and

Embarking on the journey to enter the European OEM market as a contract or component manufacturer in the medical industry? Careful planning and strategic considerations

The European orthopedic and spinal market has shown steady growth over the past years and is forecasted to continue a steady growth for the coming

You may or may not have had your annual sales meetings with your distributors, if you haven’t it’s a critical moment to set out plans,

Expanding into new markets, such as Europe or the Middle East, can be a significant opportunity for medical device manufacturers looking to grow their business.

The world is facing challenges such as geopolitical and economical events resulting into inflation and shortages in the supply chain. The new Medical Device Regulation

Why Entering the French Medical Device Market Is More Complex Than It Looks? France remains one of the most attractive healthcare markets in Europe, both

Per April 2023 Canadian medical manufacturers can apply for a funding for fiscal year 2023 and 2024! Don’t miss out on this opportunity and read

Germany is home to some of the most renowned medical device manufacturers in the world. A “made in Germany” stamp is synonymous with excellence and

The Spanish medical device (MED) market has grown to be worth €7.42 million, a number boosted by the government’s renewed support to the health sector

France is among the top 3 biggest spenders when it comes to healthcare expenditures in all of the EU. In 2018, the total healthcare expenditure

As the fourth largest medical equipment market in Europe, Italy’s high profit per capita rate seems inviting to investors and foreign companies in the Italian

Accessing the Swiss medical device market with FDA approval The swiss medtech approves medical device manufacturers enter the Swiss healthcare market with FDA. This is

Blogs & News
Is your Medical Device EU Importing 2026 strategy ready? Download our guide to navigating EUDAMED milestones, Article 13 compliance, and avoiding distributor bottlenecks.

The global healthcare landscape is evolving faster than ever, and for medical device manufacturers, the Middle East represents one of the most dynamic regions for

Every year, MedTech, Pharma, and Healthcare companies invest heavily in European tradeshows. Booths are booked, teams are flown in, brochures are printed—and yet many companies

Why Entering the French Medical Device Market Is More Complex Than It Looks? France remains one of the most attractive healthcare markets in Europe, both

In today’s healthcare landscape, patients are no longer passive recipients of information — they’re informed, digitally savvy decision-makers who research symptoms, compare providers, read reviews,

European Anesthesia Market Overview The European medical technology market as a whole is enormous – about €170 billion in 2024, making Europe the world’s second-largest

Whitepaper

Learn how non-EU medical device manufacturers can stay MDR-compliant. This whitepaper explains what qualifies as an MDR importer, the risks of designating distributors, the legal

The new EU MDR/IVDR regulations redefine the responsibilities of manufacturers, importers, and distributors—creating new risks for non-EU companies. This whitepaper explains why appointing your distributor

Europe/MENA quickly—bringing market know-how, KOL/distributor/hospital networks, and a proven outreach engine—while keeping costs, risk, and commitments low. You’ll compare SDaaS against hiring employees, independent reps,

Sucess Stories

From 14 to 55 distributors and 3.5x revenue growth in 3 years — discover how GrowthMedics helped a U.S. healthcare manufacturer scale across Europe. The

From zero presence to six exclusive distributors in 12 months—see how GrowthMedics launched a new veterinary rehab technology across Europe and the Middle East. The

When your domestic market matures, or if you are looking to scale revenue, growth means going global. Learn how GrowthMedics guided a U.S. infection control

Beyond the CE Mark: Is Your Importing Strategy EUDAMED-Ready?​

The implementation of EU MDR and IVDR is a journey of critical milestones, and the most significant one is now upon us. As the mandatory transition to EUDAMED approaches, your strategy for Medical Device EU Importing 2026 must evolve to maintain market access.

For non-EU manufacturers, holding a CE mark is no longer the final step. To maintain market access, you must now navigate the phased implementation of EUDAMED, the European database for medical devices. This isn’t just a digital filing cabinet; it is the backbone of transparency and safety in the EU.

Now is the moment to audit your importing strategy. As EUDAMED modules for Actor and Device registration become mandatory, your choice of Importer determines your ability to generate a Single Registration Number (SRN) and keep your supply chain moving.

 

Why the “Distributor-as-Importer” Model can create bottlenecks

With stricter EUDAMED oversight and Notified Body bottlenecks, the old way of importing can become a liability:

  •  Commercial “Lock-in” & Market Conflict: Tying your legal importer address to one distributor makes switching partners or adding new sales channels a labeling nightmare. You lose the flexibility to scale a multi-channel strategy.
  • The Liability & Capability Gap: Importers now share joint liability for compliance. Most distributors lack the RA/QA infrastructure to manage EUDAMED Actor profiles or perform mandatory Article 13 checks.
  • Administrative Burnout: EUDAMED requires importers to link themselves to your devices and update data within one week of any change. Many distributors are now refusing these burdens, stalling your product launch.

 

What You’ll Discover in This Practical Guide:

  • The 2026 Compliance Roadmap: Key deadlines for Actor and Device registration in EUDAMED.
  • Regulatory vs. Fiscal Silos: How to design a setup where compliance and cash flow (VAT Article 23) work in harmony.
  • The Netherlands Advantage: Why the Dutch “Hub” is the trending choice for centralized EU medical device logistics.
  • The “Importer Onboarding Pack”: A checklist of exactly what you need to prepare—from UDI-DI mapping to Quality Agreements—to avoid shipment holds.

 

Ready to guarantee importer compliance, place your medical device and In Vitro Devices seamless, efficient and independent in the EU, UK and CH markets?

GrowthMedics provides the independent, ISO 13485-standard importing infrastructure you need to bypass distributor conflict and EUDAMED delays.

  • Total Flexibility: Add or change distributors without relabeling.
  • Data Security: Your technical documentation stays with an independent regulatory partner, not a sales agent.
  • Fiscal Efficiency: Leverage our Netherlands-based expertise for seamless customs and VAT management.
 
Case Studies GrowthMedics

Ready to Expand ?

Learn how we can bring international growth success!

Our Success Stories will give you insights on how we helped introduced lifescience technologies in international markets. We explain our approach, activities and results.

Check out our success stories section for more information!

Case Studies GrowthMedics

Download and profit of the insights of the European market

Accelerating global growth

A complete guide for selling medical and IVD devices successful in Europe